Flumazenil may attenuate some subjective effects of nitrous oxide in humans: a preliminary report.
Pharmacology, biochemistry, and behavior August 1, 1995 J P Zacny, S Yajnik, D Coalson et al.
In two double-blind, randomized, crossover trials, eight healthy volunteers inhaled 30% nitrous oxide in oxygen for 35 minutes and were given flumazenil 10 minutes into the inhalation. Experiment 1 tested clinical doses of flumazenil (0, 0.25, 0.5, and 1.0 mg/70 kg), while Experiment 2 tested a supraclinical dose (0 and 5.0 mg/70 kg). Nitrous oxide increased ratings of high, drunk, and tingling and impaired psychomotor performance. Only the supraclinical flumazenil dose significantly reduced the high rating; other subjective effects showed non-significant decreases. Flumazenil did not affect nitrous oxide's psychomotor effects. The findings suggest that a high flumazenil dose may partially antagonize some subjective effects of nitrous oxide.